Understanding Your Keratoconus Diagnosis: Expert Care at ReFocus Eye Health Penndel
What Is Keratoconus?
Keratoconus is a progressive eye condition where your cornea, the clear front part of your eye, gradually thins and bulges outward into a cone shape instead of maintaining its normal dome-like curve. Understanding this diagnosis is the first step toward protecting your eyesight.
The irregular cone shape of your cornea causes light to bend unevenly as it enters your eye, leading to blurry and distorted vision that standard glasses often cannot fully correct. Recent research shows that keratoconus is more common than previously thought, affecting approximately 1 in 345 people globally, with higher rates in certain populations including those of Middle Eastern and South Asian descent. While this diagnosis may feel overwhelming, early detection and treatment give you the best chance to preserve your vision and maintain your quality of life for decades to come.
Many patients with keratoconus notice frequent changes in their eyeglass or contact lens prescription, sometimes needing updates every few months rather than every year or two. You may also experience increased sensitivity to light and glare, especially at night, making activities like driving after dark particularly challenging. Your vision may seem blurry or distorted even with your current prescription, with straight lines appearing wavy or bent. Reading, recognizing faces from a distance, or performing detailed tasks like threading a needle may become progressively more difficult.
The exact cause of keratoconus remains not fully understood, but researchers have identified several risk factors that increase your likelihood of developing this condition. Genetics plays a significant role, as keratoconus often runs in families. If you have relatives with the condition, this may explain your diagnosis. Chronic eye rubbing, often due to allergies or eye irritation, is strongly linked to both the development and progression of keratoconus. The mechanical stress from rubbing weakens the corneal structure over time. Certain systemic conditions including Down syndrome, Ehlers-Danlos syndrome, and other connective tissue disorders also increase your risk because they affect collagen strength throughout your body, including in your corneas.
Understanding Disease Progression
Keratoconus typically progresses most actively during the teenage years and twenties, then gradually stabilizes naturally by the thirties or forties after 10 to 20 years of changes. However, progression rates vary significantly from person to person, which is why monitoring is essential.
Some people experience rapid worsening over just a few years that requires prompt intervention, while others have mild cases that change very slowly over many years. If you are in your teens or twenties, your keratoconus tends to progress most rapidly during these years, which is why our ophthalmologists emphasize monitoring and early treatment for younger patients. Children and very young adults may progress aggressively and are often considered for earlier treatment at the first signs of documented change to prevent severe vision loss later.
Our team tracks several objective indicators to determine if your keratoconus is progressing. These include increases in corneal steepness measured as Kmax or steep K by 1.0 diopter or more over 6 to 12 months, increases in your manifest cylinder or nearsightedness by 0.5 to 1.0 diopter or more, thinning at the thinnest point of your cornea by 10 to 20 micrometers or more, and decline in your best-corrected vision that cannot be explained by other causes like cataracts or dry eye. We use advanced corneal imaging technology to precisely measure these changes at each visit.
If you notice your vision changing rapidly between appointments, your contact lenses fitting differently than they used to, or increasing difficulty with daily activities, these subjective symptoms suggest active progression that requires evaluation.
What Corneal Cross-Linking Can Do for You
Corneal cross-linking, often abbreviated as CXL, is the only FDA-approved treatment in the United States that can stop keratoconus from getting worse. The procedure strengthens your cornea by creating new chemical bonds between collagen fibers, similar to how bridges use cross-bracing for structural support.
Cross-linking successfully halts progression in approximately 90 to 95 percent of patients treated for progressive keratoconus. When performed early in the disease course, it substantially lowers the chance that you will ever need a corneal transplant. Clinical studies demonstrate that most patients maintain stable vision and corneal shape for 10 years or more after a single treatment, making this a highly effective long-term solution.
Cross-linking is designed to stop progression and prevent future vision loss, not to cure keratoconus or immediately restore vision you have already lost. Think of it as preventing further damage rather than reversing damage already done. Your vision will temporarily worsen during the first 1 to 2 weeks as your corneal surface heals, with gradual improvement typically occurring over the following 3 to 6 months. This initial blur is a normal part of healing and does not indicate treatment failure.
Many patients experience a beneficial side effect of slight corneal flattening, typically 1 to 2 diopters, and better corneal regularity over 6 to 12 months after treatment. This flattening can sometimes improve your vision quality or make contact lens fitting easier, though this is not the primary goal. Most patients will still need glasses or specialized contact lenses after cross-linking to achieve their clearest vision, but your prescription should remain stable rather than continually worsening.
Are You a Candidate for Cross-Linking?
Not everyone with keratoconus needs cross-linking immediately. Our ophthalmologists will recommend the procedure if they can document that your condition is actively progressing through serial measurements over 6 to 12 months showing changes in corneal shape, prescription, or vision. For pediatric and very young adult patients, we often favor earlier treatment at the first documented change due to their higher risk of rapid progression.
Ideal candidates have progressive keratoconus, meaning their vision and corneal shape are actively worsening over time rather than remaining stable. The treatment is especially effective and important for teenagers and young adults when the disease is typically most active and aggressive. Early intervention prevents severe progression that could severely limit your vision correction options and quality of life later. Patients who undergo cross-linking before developing advanced corneal steepness or scarring tend to have better long-term outcomes.
If your keratoconus has remained stable for more than two years with no measurable changes in corneal shape, thickness, or vision, cross-linking may not provide additional benefit right now and we may recommend continued monitoring instead. Our ophthalmologists make this determination through serial corneal topography and tomography measurements performed at regular intervals, carefully comparing your current corneal shape and thickness to previous measurements to detect even subtle changes. Stable keratoconus, particularly in patients over 40, may never require cross-linking.
Certain conditions may prevent you from being a candidate for standard corneal cross-linking. These include having a cornea that is too thin to safely treat, as we aim to maintain at least 400 micrometers of corneal thickness during ultraviolet light exposure after the surface layer is removed to protect the inner eye structures. Severe corneal scarring, active eye infections, pregnancy or breastfeeding, and a history of herpes simplex eye infections may also affect your candidacy. A prior history of ocular herpes is a relative rather than absolute contraindication, and our team may recommend antiviral medication before and after treatment to prevent reactivation. Certain autoimmune disorders that could impair corneal healing require careful evaluation.
If your cornea is thinner than the standard safety limit for conventional cross-linking, our surgeons may be able to use modified techniques depending on your specific situation. These approaches include using hypotonic riboflavin solutions to temporarily swell the cornea to a safer thickness, contact lens-assisted protocols that add extra thickness during treatment, epithelium-on approaches that preserve the surface layer, or iontophoresis-assisted cross-linking that uses gentle electrical current to enhance riboflavin penetration. Our team will discuss which modified approach, if any, is appropriate for your corneal characteristics.
What to Expect from the Procedure
Corneal cross-linking is a straightforward outpatient procedure performed right here at ReFocus Eye Health Penndel that typically takes 60 to 90 minutes from start to finish. You will remain awake and comfortable throughout the treatment with numbing eye drops, and you will go home the same day.
There are two main surgical approaches. In epithelium-off cross-linking, also called epi-off, our surgeon gently removes the thin outer protective layer of your cornea called the epithelium to allow better absorption of the riboflavin solution. This is the most extensively studied and reliable method, especially for progressive or advanced keratoconus, with the strongest evidence for effectiveness. In epithelium-on cross-linking, also called epi-on, this protective layer is left intact for potentially faster healing and less initial discomfort, though riboflavin absorption and treatment efficacy can be more variable with this approach. Our ophthalmologists will recommend the best approach based on your specific corneal characteristics, disease severity, age, and individual needs.
The cross-linking procedure generally follows these careful steps. First, numbing drops are applied to your eye to ensure complete comfort throughout the procedure. You should not feel pain during treatment, though you may feel pressure or awareness of the instruments. For epithelium-off procedures, the thin outer corneal layer is gently removed over a 7 to 9 millimeter central area. Next, riboflavin eye drops, which contain vitamin B2, are applied to your eye every few minutes for approximately 30 minutes to thoroughly saturate the corneal tissue. We confirm that your corneal thickness is at or above 400 micrometers before beginning the ultraviolet light exposure to ensure safety. A specialized ultraviolet light device is then positioned over your eye to activate the riboflavin. Treatment protocols vary, with the classic Dresden protocol using lower intensity light for about 30 minutes and accelerated protocols using higher intensity light for shorter periods of about 3 to 10 minutes. Finally, your eye is thoroughly rinsed, antibiotic and anti-inflammatory drops are applied, and a soft bandage contact lens is placed over your cornea to protect the healing surface for the next 5 to 7 days.
You will need to stop wearing contact lenses before your evaluation and treatment because lenses temporarily alter corneal shape and thickness, which could affect our measurements and treatment planning. Plan for approximately 3 to 7 days out of soft contact lenses, and 2 to 4 weeks or sometimes longer out of rigid gas permeable, hybrid, or scleral lenses depending on your specific lens type and wear pattern. Arrange reliable transportation home after your procedure, as your vision will be quite blurry and you will be very light-sensitive immediately afterward. Plan to take 3 to 5 days off work or school for the initial recovery period when discomfort and blur are most significant.
Your Recovery Journey
Recovery from corneal cross-linking occurs in distinct phases over several months. Understanding what to expect during each phase helps you prepare mentally and manage the process with realistic expectations.
Expect mild to sometimes moderate or even severe discomfort for the first 3 to 5 days as your corneal surface regenerates and heals. Pain levels vary widely between patients, with some experiencing only mild irritation while others have significant discomfort requiring prescription pain medication. Your vision will be very blurry during this time, making reading or screen work difficult or impossible. You will also be quite sensitive to light, so wearing dark wraparound sunglasses both indoors and outdoors is very helpful. Use your prescribed antibiotic and steroid eye drops exactly as directed to prevent infection and control inflammation. Avoid rubbing or touching your treated eye. Wear the protective eye shield we provide while sleeping for at least the first week to prevent accidental rubbing or injury during sleep.
Our team will remove your bandage contact lens once your corneal surface has completely healed, usually 5 to 7 days after surgery at your first follow-up appointment. Most patients notice that discomfort improves dramatically after lens removal, though some irritation, dryness, and foreign body sensation remain common for several more weeks. Your vision begins improving during this phase but remains blurry and fluctuating as your cornea continues healing and remodeling. You may notice cloudiness or haze in your vision, which is a typical part of the healing process and usually resolves gradually over the next few months.
Vision continues improving and stabilizing during this period, though day-to-day fluctuations can persist, especially in the morning or when your eyes are tired or dry. The corneal haze gradually clears, with many patients seeing significant improvement by month 3. Most patients can carefully restart contact lens wear around 4 to 8 weeks under our guidance if the corneal surface looks healthy, smooth, and regular on examination. We will work closely with you to ensure proper lens fitting once your cornea has stabilized enough.
Final visual outcomes typically become fully apparent 6 to 12 months after treatment when corneal remodeling is complete. Corneal strengthening reaches its maximum effect around one year post-treatment, though biomechanical changes continue to mature beyond this point. The vast majority of patients maintain stable corneas indefinitely after cross-linking. A small minority of patients, approximately 3 to 10 percent over several years with higher rates in pediatric or very steep cases, may need repeat cross-linking if progression resumes. Our team monitors you long-term to detect any rare late changes.
- Use all prescribed eye drops exactly as directed on your medication schedule. Set phone reminders if needed to stay on track.
- Avoid rubbing or touching your treated eye to prevent damage to the healing corneal surface and reduce infection risk.
- Rest your eyes frequently and avoid strenuous exercise, heavy lifting, or dusty or dirty environments for at least the first week after surgery.
- Take over-the-counter pain relievers like acetaminophen or ibuprofen before discomfort becomes severe, if approved by our team.
- Apply cool compresses over your closed eyelid for 10 to 15 minutes several times daily to soothe discomfort and reduce swelling.
- Keep indoor lights dim and limit time on bright screens during the first week when light sensitivity is most pronounced.
- Wear your protective eye shield during all sleep, including naps, for at least one week.
- Avoid swimming, hot tubs, saunas, and eye makeup for at least 1 to 2 weeks to prevent contamination and infection.
- Attend all scheduled follow-up visits so our ophthalmologists can monitor your healing and address any concerns early.
Understanding Risks and Warning Signs
While corneal cross-linking is very safe with a low overall complication rate based on millions of procedures performed worldwide, it is important to understand potential risks and know when to contact our office immediately.
Nearly all patients experience certain temporary side effects that are expected parts of the healing process. These include temporary vision reduction worse than your baseline for the first few weeks, mild to moderate corneal haze or cloudiness that gradually clears, eye irritation and foreign body sensation as the surface heals, light sensitivity especially during the first week, and mild to moderate discomfort or pain during the first 3 to 5 days. Temporary dryness is also very common and typically responds well to preservative-free lubricating eye drops used frequently. A small percentage of patients report persistent dry eye symptoms lasting months, though this is uncommon.
Serious complications are rare but can occur. Corneal infection develops in fewer than 1 percent of cases, typically presenting as increasing rather than decreasing pain, progressive redness, and yellow or green discharge 2 to 7 days after treatment. Infections require prompt antibiotic treatment. Delayed corneal surface healing affects approximately 2 to 5 percent of patients and may require extended bandage contact lens wear and more frequent monitoring. Persistent visually significant corneal haze or scarring beyond 6 months is uncommon, occurring in about 1 to 2 percent of cases, with higher risk in very young patients or those with very steep corneas exceeding 58 to 60 diopters. If you have a prior history of cold sores or herpes simplex eye disease, there is a risk of viral reactivation triggered by the procedure, which is why our ophthalmologists may prescribe antiviral medication as a preventive measure.
- Pain that increases rather than decreases after the first 48 hours
- Severe pain that is not controlled by your prescribed pain medications
- Worsening redness or development of yellow or green discharge from your eye
- Sudden vision loss or new white or cloudy spots appearing on your cornea
- Loss or displacement of your bandage contact lens before your scheduled removal appointment
- New or worsening light sensitivity if you have a history of cold sores or ocular herpes
Early recognition and prompt treatment of complications prevent most serious long-term problems. Never hesitate to contact ReFocus Eye Health Penndel if you have concerns during your recovery.
Living with Keratoconus: What Happens Next
Managing keratoconus successfully is a long-term commitment that involves protecting your vision through lifestyle measures, optimizing your vision correction with appropriate lenses, and staying connected with our eye care team for regular monitoring.
The single most important thing you can do after your keratoconus diagnosis is to completely avoid rubbing your eyes, no matter how itchy they feel. Manage eye allergies aggressively with oral antihistamines, prescription allergy eye drops, or allergy immunotherapy if recommended by your allergist, since reducing the urge to rub is critical. Wear protective eyewear during sports, yard work, and other high-risk activities to prevent eye trauma. Continue treating any underlying conditions like chronic dry eye, blepharitis, or meibomian gland dysfunction that could affect your corneal health. If you become pregnant, be aware that pregnancy hormones can occasionally be associated with corneal changes, so we typically defer elective cross-linking during pregnancy and breastfeeding and recommend closer monitoring during this time.
Most people with keratoconus will need specialized contact lenses or glasses to achieve their best functional vision for daily activities. Regular eyeglasses may work adequately for very mild keratoconus in its earliest stages, but as the condition progresses and corneal irregularity increases, specialized contact lenses become necessary for clear vision. Our optical department at ReFocus Eye Health Penndel offers several options including rigid gas permeable lenses that create a smooth new refractive surface over the irregular cornea, scleral lenses that vault completely over the cornea and rest on the white part of your eye for excellent vision and all-day comfort even in moderate to advanced cases, and hybrid lenses that combine a rigid center with a soft skirt for a balance of clarity and comfort. For patients who need additional help beyond lenses, we can discuss options to reshape corneal optics and improve visual quality, including intrastromal corneal ring segments that are tiny implants placed in the cornea to flatten the cone, and in carefully selected cases with adequate corneal thickness, topography-guided laser vision correction combined with simultaneous cross-linking once the disease is documented as stable. These surgical options do not halt progression by themselves and are typically combined with or performed after cross-linking.
Continue regular comprehensive eye examinations at intervals recommended by our ophthalmologists, especially during the first several years after diagnosis when changes occur most rapidly. For progressive keratoconus, we typically recommend monitoring every 3 to 6 months, while stable keratoconus may only require annual visits. These monitoring visits allow us to watch for any rare late progression, assess your overall corneal and ocular health, screen for other eye conditions, and update your vision correction as needed to maintain your best possible sight.
Insurance and Financial Planning
Understanding the financial aspects of keratoconus treatment helps you plan for the comprehensive care you need without unexpected surprises.
Most medical insurance plans in the United States, including commercial insurance, Medicare, and Medicaid, cover FDA-approved corneal cross-linking when medical necessity is clearly documented. Medical necessity typically requires our ophthalmologists to demonstrate objective evidence of keratoconus progression over 6 to 12 months through serial corneal imaging and measurements. Pre-authorization is usually required before scheduling your procedure, and our knowledgeable staff works closely with your insurance company to obtain authorization and verify your coverage and out-of-pocket costs.
If your insurance denies coverage, you do not yet have insurance, or you have a high-deductible plan, corneal cross-linking typically costs $3,000 to $5,000 per eye, including the procedure itself and standard follow-up visits during the first few months. Many practices including ReFocus Eye Health Penndel offer flexible payment plans or healthcare financing options to make treatment more affordable. Consider that this investment in stopping disease progression may prevent much higher future expenses associated with progressive keratoconus, including increasingly complex and expensive specialty contact lenses costing hundreds to thousands of dollars annually, and in severe untreated cases, corneal transplant surgery that can cost $25,000 to $40,000 per eye with months of recovery and years of follow-up care.
Frequently Asked Questions
Our patients commonly ask similar questions about keratoconus and cross-linking treatment. Here are answers to the most frequent concerns we hear.
No. While keratoconus can significantly impact your vision quality and ability to perform detailed tasks, it rarely if ever causes complete blindness or total vision loss. With appropriate treatment including cross-linking when needed and proper vision correction with specialty lenses, the vast majority of people with keratoconus maintain functional vision throughout their lives that allows them to work, drive, and perform daily activities successfully.
Treatment approaches vary based on surgeon preference and your specific situation. Many surgeons including our team prefer to treat one eye at a time and wait 1 to 3 months between procedures so you can function reasonably well while the first eye heals, since both eyes will be quite blurry if treated simultaneously. However, some specialized centers offer same-day bilateral epithelium-off cross-linking for carefully selected patients who can arrange significant help at home during recovery. We will discuss which approach makes the most sense for your lifestyle, work demands, and support system.
The optimal timing depends entirely on whether your keratoconus is actively progressing or currently stable. Our ophthalmologists determine this through serial corneal measurements obtained over 6 to 12 months that document changes in corneal steepness, thickness, and shape. If your keratoconus is progressing, we generally recommend proceeding with cross-linking relatively soon, within a few months of documenting progression, to prevent additional vision loss. Rapidly progressing cases, particularly in teenagers and young adults, should prioritize treatment promptly. For pediatric patients and very young adults in their teens or early twenties, we often recommend earlier treatment at the first documented change rather than waiting for more significant progression due to their much higher risk of rapid worsening.
If your keratoconus is documented as actively progressing and you choose not to pursue corneal cross-linking treatment, the condition will almost certainly continue worsening over time at an unpredictable rate. Progressive worsening typically leads to increasingly difficult and expensive specialty contact lens fitting as your cornea becomes steeper and more irregular, progressively poorer vision despite best correction that interferes with work and daily activities, and in severe advanced cases, possible need for corneal transplant surgery with its associated risks, prolonged recovery, and lifelong follow-up requirements. However, if your disease has remained completely stable for extended periods of two years or more based on objective measurements, continued observation with regular monitoring every 6 to 12 months may be entirely appropriate without immediate treatment.
Schedule Your Comprehensive Evaluation
If you have been diagnosed with progressive keratoconus or suspect your condition may be worsening based on changing vision or contact lens fit, we encourage you to schedule a comprehensive evaluation with our experienced ophthalmologists at ReFocus Eye Health Penndel. Serving patients throughout Penndel, Levittown, Bensalem, Bristol, and the greater Philadelphia region including Bucks, Montgomery, and Philadelphia Counties, our team provides advanced diagnostic imaging and personalized treatment planning to determine whether corneal cross-linking is right for you. While a keratoconus diagnosis can feel overwhelming at first, modern treatments like corneal cross-linking combined with excellent specialty contact lenses provide real hope for stopping progression, preserving your vision, and maintaining your quality of life for decades to come.
First time at Refocus, 1st class team! Funny, professional girls. Services: laser therapy, Botox, eye exams. Dr. Soll caring, explains prevention. Thanks Refocus! Great Team 🤙
Chris Gray
Super job by Dr. Martinez and the entire team. Highly recommend. Thank you for your care.
Bill Hyndman
Dr. Amin is knowledgeable, kind, and sympathetic. She listens carefully and provides excellent care. Truly a wonderful doctor who makes patients feel valued and understood. Highly recommend!
Sarah Magee
Suffering since Jan with pain, Wills Eye couldn’t figure it out. Dr. Soll gave same-day appt, removed it. Felt better! Dr. Soll is a God send. Forever grateful. Best ophthalmologist ever!!!
Cam Fen
First visit, positive. Friendly staff, no wait. Pre-doctor exam thorough. Dr. Bano wonderful and funny. Alex helped with glasses, knowledgeable, humorous. I really enjoyed my visit!
Aimée Robidoux
Contact Us
Tuesday: 12-6PM
Wednesday: Closed
Thursday: Closed
Friday: 9AM-4PM
Saturday: Closed
Sunday: Closed